On Tuesday, Shares of JetBlue Airways Corporation (NASDAQ:JBLU), gained 2.09% to $22.45, hitting its highest level.
JetBlue Airways Corporation, declared that it will hold its quarterly conference call to talk about second quarter 2015 financial results on July 28, 2015 at 10:00 a.m. ET.
A live, listen-only webcast of the call will be accessible on JetBlue’s investor relations website at the following web address: http://investor.jetblue.com
For those unable to listen to the live webcast, it will also be archived on JetBlue’s investor relations website under ‘Audio Archives’ following the conference call.
JetBlue Airways Corporation, a passenger carrier company, provides air transportation services. As of December 31, 2014, the company operated a fleet of 13 Airbus A321 aircrafts, 130 Airbus A320 aircrafts, and 60 EMBRAER 190 aircrafts. It also served 87 destinations in 27 states in the United States (the U.S.), the District of Columbia, the Commonwealth of Puerto Rico, the U.S. Virgin Islands, and 17 countries in the Caribbean and Latin America.
Shares of Celgene Corporation (NASDAQ:CELG), inclined 1.62% to $122.85, during its last trading session.
Celgene Corporation, and Receptos, Inc. (RCPT) declared the signing of a definitive agreement in which Celgene has agreed to acquire Receptos. Under the terms of the merger agreement, Celgene will pay $232.00 per share in cash, or a total of about $7.2 billion, net of cash attained.
The acquisition of Receptos significantly enhances Celgene’s Inflammation & Immunology (I&I) portfolio, further diversifies the Company’s revenue startning in 2019 and beyond, and builds upon Celgene’s growing expertise in inflammatory bowel disease (IBD). The transaction adds Ozanimod, a novel, potential best-in-class, oral, once-daily, selective sphingosine 1-phosphate 1 and 5 receptor modulator (S1P) to Celgene’s deep and diverse pipeline of potential disease-altering medicines and investigational compounds.
Celgene Corporation, a biopharmaceutical company, discovers, develops, and commercializes therapies to treat cancer and inflammatory diseases in the United States and Internationally.
Finally, Plains GP Holdings, L.P. (NYSE:PAGP), ended its last trade with 1.61% gain, and closed at $26.44.
Plains All American Pipeline, L.P. and Plains GP Holdings, declared several executive promotions at PAA. John Keffer and Sam Brown have each been promoted to the positions of Senior Vice President, and Jeremy Goebel and James Pinchback have each been promoted to the positions of Vice President.
John R. Keffer, Senior Vice President, joined PAA in 1998 and has served in a number of positions of increasing responsibility counting Managing Director – Refinery Supply, Director of Trading and Manager of Sales and Trading. Most recently, Mr. Keffer served as Vice President Terminals, with primary responsibility for managing the commercial operations in our crude and products terminals.
Sam N. Brown, Senior Vice President, joined PAA in 2009 as Vice President, Pipeline Business Development, with primary responsibility for the commercial activities for all crude oil and refined product pipelines in the U.S.
Plains GP Holdings, L.P., through its interest in Plains AAP, L.P., owns and operates midstream energy infrastructure and provides logistics services for crude oil, natural gas liquids, natural gas, and refined products in the United States and Canada. The company operates through three segments: Transportation, Facilities, and Supply and Logistics.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.
